Here are the 424B prospectus supplements from Aehr Test Systems (AEHR) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow AEHR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AEHR filings page.
Aehr Test Systems is registering an at-the-market offering to sell up to $60,000,000 of its common stock through an Equity Distribution Agreement with William Blair and Craig-Hallum dated April 8, 2026. The offering may be made from time to time at prevailing market prices and the agents will receive commissions up to 3.00%.
The prospectus supplement states the company may use net proceeds for general corporate purposes including working capital, inventory, research and development, commercial activities and capital expenditures. The company reported 30,953,752 shares outstanding as of February 27, 2026 and referenced a last reported sale price of $52.16 per share on April 6, 2026.